FOXP3 and gastric cancer: In the subgroup study of advanced gastric cancer patients, there was no significant difference of patient characteristics in age, gender, LN metastasis, distant metastasis, HP infection, tumor-infiltrated CD4 T cells and tumor-infiltrated Foxp3+ T cells (Table 2).